US70975L1070 - Common Stock
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 36th Annual Healthcare...
The latest news from the lab, plus an analyst's bullish move, combined to put some zip in the company's shares.
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2024 after...
The company might just be the right kind of business operating at the right time in history.
Latest computer assisted vacuum thrombectomy (CAVT) technologies combine superior catheter design with the latest dual clot detection computer algorithms...
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Baird Global Healthcare Conference on...
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on...
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced that its Board of Directors approved on August 5, 2024 a...
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity Growth Conference on...
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news happening this morning!
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penumbra (NYSE:PEN) just reported results for the second quarter of 2024.Penumb...
PEN stock results show that Penumbra beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second...
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2024 after...